{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:37:14Z","timestamp":1785551834096,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304297"],"award-info":[{"award-number":["82304297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077018"],"award-info":[{"award-number":["22077018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117271","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T15:05:50Z","timestamp":1736694350000},"page":"117271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to C NNH2-Biphenyl-Diarylpyrimidines"],"prefix":"10.1016","volume":"285","author":[{"given":"Xiao-Mei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xuan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dettori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen-Er","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117271_bib1","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/s41467-021-21816-x","article-title":"Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation","volume":"12","author":"Jette","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117271_bib2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.apsb.2021.11.009","article-title":"Approved HIV reverse transcriptase inhibitors in the past decade","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117271_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2796.2007.01910.x","article-title":"The first postmodern pandemic: 25 years of HIV\/AIDS","volume":"263","author":"Kallings","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejmech.2025.117271_bib5","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib6","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2005.11.021","article-title":"Update on HAART in HIV","volume":"44","author":"Yeni","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117271_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1916753","article-title":"Four decades of HIV\/AIDS - much accomplished, much to do","volume":"383","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117271_bib8","doi-asserted-by":"crossref","first-page":"15608","DOI":"10.1021\/acs.jmedchem.2c00576","article-title":"Lead optimization and avoidance of metabolic-perturbing motif developing novel diarylpyrimidines as potent HIV-1 NNRTIs","volume":"65","author":"Sun","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108261","article-title":"Structure-directed expansion of biphenyl-pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with significantly improved potency and safety","volume":"34","author":"Zhao","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117271_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.07.006","article-title":"Linker optimization of HEPT derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors: from S=O to CHOR","volume":"34","author":"Hao","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117271_bib11","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1016\/j.apsb.2023.07.008","article-title":"Structure-based design of novel heterocycle-substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility","volume":"13","author":"Zhao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117271_bib12","first-page":"1","article-title":"Deciphering the enigmas of non-nucleoside reverse transcriptase inhibitors (NNRTIs): a medicinal chemistry expedition towards combating HIV drug resistance","author":"Zhang","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117271_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/med.21544","article-title":"Challenges and approaches in the discovery of human immunodeficiency virus type-1 non-nucleoside reverse transcriptase inhibitors","volume":"39","author":"Battini","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117271_bib14","doi-asserted-by":"crossref","first-page":"17568","DOI":"10.1021\/acs.jmedchem.4c01571","article-title":"Fragment addition-based design of heteroaromatic-biphenyl-DAPYs as potent and orally available non-nucleoside reverse transcriptase inhibitors featuring significantly enhanced safety","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.apsb.2018.01.012","article-title":"Anti-retroviral drugs: current state and development in the next decade","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117271_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmech.2018.09.013","article-title":"Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors","volume":"158","author":"Gu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.apsb.2019.11.010","article-title":"Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years","volume":"10","author":"Zhuang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117271_bib18","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/med.21760","article-title":"Druggability modification strategies of the diarylpyrimidine-type non-nucleoside reverse transcriptase inhibitors","volume":"41","author":"Ding","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117271_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116668","article-title":"Structure-based discovery of novel piperidine-biphenyl-DAPY derivatives as non-nucleoside reverse transcriptase inhibitors featuring improved potency, safety, and selectivity: from piperazine-biphenyl-DAPYs to piperidine-biphenyl-DAPYs","volume":"276","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.apsb.2023.11.023","article-title":"Structure-based design and optimization lead to the identification of novel dihydrothiopyrano[3,2-d]pyrimidine derivatives as potent HIV-1 inhibitors against drug-resistant variants","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117271_bib21","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.2c01574","article-title":"Design and synthesis of novel HIV-1 NNRTIs with bicyclic cores and with improved physicochemical properties","volume":"66","author":"Prener","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib22","doi-asserted-by":"crossref","first-page":"19889","DOI":"10.1021\/acs.jmedchem.4c02413","article-title":"Expanding the solvent\/protein region occupation of the non-nucleoside reverse transcriptase inhibitor binding pocket for improved broad-spectrum anti-HIV-1 efficacy: from rigid phenyl-diarylpyrimidines to flexible hydrophilic piperidine-diarylpyrimidines","volume":"67","author":"Huang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib23","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/molecules25051050","article-title":"Design of biphenyl-substituted diarylpyrimidines with a cyanomethyl linker as HIV-1 NNRTIs via a molecular hybridization strategy","volume":"25","author":"Lei","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117271_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2016.06.026","article-title":"Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl) methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1","volume":"122","author":"Simon","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103825","article-title":"Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1","volume":"99","author":"Yang","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112549","article-title":"Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors","volume":"202","author":"Chen","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmech.2016.06.056","article-title":"Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1","volume":"123","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117271_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.gresc.2020.06.001","article-title":"Robust NHC-palladacycles-catalyzed Suzuki\u2212Miyaura cross-coupling of amides via C-N activation","volume":"1","author":"Deng","year":"2020","journal-title":"Green Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.117271_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.gresc.2021.10.002","article-title":"Palladium-catalyzed sulfonylative coupling of benzyl(allyl) carbonates with arylsulfonyl hydrazides","volume":"3","author":"Gong","year":"2022","journal-title":"Green Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.117271_bib30","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3390\/molecules26092717","article-title":"A validated LC-MS\/MS assay for the simultaneous quantification of the FDA-approved anticancer mixture (Encorafenib and Binimetinib): metabolic stability estimation","volume":"26","author":"Attwa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117271_bib31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/0471141755.ph0706s19","article-title":"Determination of the stability of drugs in plasma","volume":"19","author":"Hartman","year":"2002","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117271_bib32","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1021\/acs.jmedchem.3c00275","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T04:48:47Z","timestamp":1740372527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"alternative-id":["S0223523425000364"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117271","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based discovery of novel diarylpyrimidines as potent and selective Non-Nucleoside reverse transcriptase inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to CNNH2-Biphenyl-Diarylpyrimidines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117271"}}